RB

Rajendra Bajrang Upadhyay

Active Director Director DIN 11615901
DIN 11615901 First appointment Mar 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajendra Bajrang Upadhyay

Data last updated:

Rajendra Bajrang Upadhyay is a Director at Preetman Pharma Private Limited (since 2026). The company operates in Pharma.

DIN 11615901
Primary Designation Director
Industry Pharma
First Appointment 18 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Preetman Pharma Private Limited U21001GJ2026PTC175164
Director18 Mar 20262026Active

Board colleagues of Rajendra Bajrang Upadhyay

NameDINCompanyDesignation
Nikesh Jitendrabhai Patel11615900Preetman Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Preetman Pharma Private Limited
Premium access

Shareholding and investment profile for Rajendra Bajrang Upadhyay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendra Bajrang Upadhyay

Rajendra Bajrang Upadhyay currently holds 1 directorship: Preetman Pharma Private Limited (Director, since 18 Mar 2026).

Rajendra Bajrang Upadhyay was first appointed on 18 Mar 2026 as Director at Preetman Pharma Private Limited.

The current boards of Rajendra Bajrang Upadhyay's companies include Nikesh Jitendrabhai Patel (Preetman Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available